TITLE:
Performance of single reshaped Judkins left catheter for transradial coronary angiography
AUTHORS:
Guangming Zhang, Wei Cui, Ruiqin Xie, Fan Liu, Guoqiang Gu, Jingchao Lu, Hongmei Zheng, Xiuchun Yang, Xiaohong Yang
KEYWORDS:
Coronary Angiography; Transradial; Judkins Left Catheter
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.3 No.9,
December
23,
2013
ABSTRACT: Background: To investigate the feasibility of single
reshaped Judkins left catheter for transradial coronary angiography. Methods: A
total of 198 consecutive patients were enrolled in the first step study. Patients
were randomly assigned to brachial type catheter group (BRACT group) or Judkins
left catheter group (Judkins group). The inclusion criterion was the left
coronary angiography which could be accomplished by either a brachial type
catheter or a reshaped Judkins left catheter. The successful procedure was
defined as both right and left coronary angiography could be completed with a
single reshaped Judkins left catheter or a brachial type catheter. Furthermore,
1873 consecutive patients were continuously enrolled to observe the success
rate of single Judkins left catheter for transradial coronary angiography. Results:
Of the 198 patients, 191 were finally enrolled in this study according to the
inclusion criteria, with 95 patients in BRACT group and96 inJudkins group. There were no significant differences
on baseline between the two groups. Procedure success rate was 84.10% with a fluoroscopic
exposure time of 3.81 ± 0.43 min in BRA-CT group, and 81.60% with a fluoroscopic
exposure time of 4.05 ± 0.48 min in Judkins group (P > 0.05). No severe complications were found in either of the
two groups. The success rates of 1869 patients with single Judkins left
catheter for transradial coronary angiography were 75.33%. There were no complications in those patients. Conclusions:
Transradial coronary angiography with a reshaped single Judkins left catheter
is feasible and practical, with an accepted procedure success rate. This method
should be worthy of further clinical validation in a larger scale population.